The RaDiCEA Project: cost of illness (COI) analysis applied to Cryopyrin Associated Periodic Syndromes (CAPS)

類似資料

• Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS)
  著者:: Trieste, L, 等
  出版事項: (2015)
• PW02-027 - CAPS and cost-effectiveness analysis project
  著者:: Alberighi, O Della Casa, 等
  出版事項: (2013)
• National CAPS (Cryopyrin-Associated Periodic Syndrome) Registry
  著者:: Bibalo, C, 等
  出版事項: (2011)
• Canakinumab in the routinary clinical practice in cryopyrin-associated periodic syndromes (CAPS): one year of follow-up
  著者:: Martini A, 等
  出版事項: (2011-09-01)
• Canakinumab in the routinary clinical practice in cryopyrin-associated periodic syndromes (CAPS): one year of follow-up
  著者:: Caorsi, R, 等
  出版事項: (2011)